To assess cancer-specificity, promoters’ methylation levels of APC, BRCA1, CCND2, FOXA1, PSAT1, RASSF1A and SCGB3A1 were evaluated in Cohort #1 (BrC and NBr tissue samples). Here, RASSF1 is linked to cancer.